Psoriasis

Effects of bDMARDs on quality of life in patients with psoriatic arthritis: meta-analysis
Yuqiong Lu, Zhanjing Dai, Yun Lu, Feng Chang

BMJ Open Apr 2022, 12 (4) e058497; DOI: 10.1136/bmjopen-2021-058497
Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients’ satisfaction: a cross-sectional survey by patient organisations
Kayoko Kaneko, Daniel Prieto-Alhambra, Clare Jacklin, Ailsa Bosworth, Sally Dickinson, Sarah Berry, Helen McAteer, Peter C Taylor

BMJ Open Feb 2022, 12 (2) e050949; DOI: 10.1136/bmjopen-2021-050949
Prevalence of autoimmune thyroid disease in patients with psoriasis: a meta-analysis
Xiaochao Zhang, Suhan Zhang, Ruifang Wu, Siying Li, Yuwen Su, Peng Zhang

BMJ Open Jan 2022, 12 (1) e055538; DOI: 10.1136/bmjopen-2021-055538
Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial
Fabian Proft, Murat Torgutalp, Burkhard Muche, Valeria Rios Rodriguez, Maryna Verba, Denis Poddubnyy

BMJ Open Nov 2021, 11 (11) e048647; DOI: 10.1136/bmjopen-2021-048647
IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)
Kilian Eyerich, Peter Weisenseel, Andreas Pinter, Knut Schäkel, Khusru Asadullah, Sven Wegner, Ernesto J Muñoz-Elias, Holger Bartz, Friedmann J H Taut, Kristian Reich

BMJ Open Sep 2021, 11 (9) e049822; DOI: 10.1136/bmjopen-2021-049822
Expectation-induced enhancement of pain, itch and quality of life in psoriasis patients: study protocol of a randomised controlled trial
Stefanie Hölsken, Frederik Krefting, Manfred Schedlowski, Wiebke Sondermann

BMJ Open Sep 2021, 11 (9) e047099; DOI: 10.1136/bmjopen-2020-047099
Effectiveness of interdisciplinary combined dermatology–gastroenterology–rheumatology clinical care compared to usual care in patients with immune-mediated inflammatory diseases: a parallel group, non-blinded, pragmatic randomised trial
Kasper Fjellhaugen Hjuler, Anders Dige, Jørgen Agnholt, Trine Bay Laurberg, Anne Gitte Loft, Louise Faurskov Møller, Robin Christensen, Lars Iversen

BMJ Open Apr 2021, 11 (4) e041871; DOI: 10.1136/bmjopen-2020-041871
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare
Siew Eng Choon, Mark G Lebwohl, Slaheddine Marrakchi, A David Burden, Tsen-Fang Tsai, Akimichi Morita, Alexander A Navarini, Min Zheng, Jinhua Xu, Hamida Turki, Sushmita Rajeswari, Hongjie Deng, Kay Tetzlaff, Christian Thoma, Hervé Bachelez

BMJ Open Mar 2021, 11 (3) e043666; DOI: 10.1136/bmjopen-2020-043666
Risk factors for mental illness in adults with atopic eczema or psoriasis: protocol for a systematic review
Elizabeth I Adesanya, Yochai Schonmann, Joseph F Hayes, Rohini Mathur, Amy R Mulick, Lauren Rayner, Liam Smeeth, Catherine H Smith, Sinéad M Langan, Kathryn E Mansfield

BMJ Open Dec 2020, 10 (12) e038324; DOI: 10.1136/bmjopen-2020-038324
New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in Germany
Christine Blome, Natalia Kirsten, Ibrahim Nergiz, Ulrich Schiffner, Marina Otten, Matthias Augustin

BMJ Open Dec 2020, 10 (12) e039227; DOI: 10.1136/bmjopen-2020-039227

Main menu

Psoriasis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Psoriasis

Pages